Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.63 -0.11 (-2.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Taysha Gene Therapies (TSHA) reported Return on Capital Employed [ROCE] of -42.61% for Q2 2026, up 2.04 percentage points from -44.66% a year earlier and up 1.32 percentage points from the prior quarter.

Analysis

Taysha Gene Therapies (TSHA) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Taysha Gene Therapies posted Return on Capital Employed [ROCE] of -49.05%, up 16.13 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -13.89 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -65.18% in FY2024 (-0.93 pp), -64.25% in FY2023 (+87.11 pp), -151.36% in FY2022 (-57.53 pp) and -93.82% in FY2021 (-58.67 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -291.63% in Q2 2023 and a high of -34.47% in Q3 2025.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last five quarters, with an average year-over-year change of +9.37 percentage points over the last seven quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2023 (a gain of 240.55 percentage points); the low point was Q4 2022 (a drop of 191.07 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -43.93% (Q1 2026), -36.42% (Q4 2025) and -34.47% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Taysha Gene Therapies 1.51 Bn 1.51 Bn - -42.61%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.61%
Mar 31, 2026 -43.93%
Dec 31, 2025 -36.42%
Sep 30, 2025 -34.47%
Jun 30, 2025 -44.66%
Mar 31, 2025 -69.83%
Dec 31, 2024 -63.49%
Sep 30, 2024 -54.53%
Jun 30, 2024 -54.82%
Mar 31, 2024 -64.57%
Dec 31, 2023 -49.11%
Jun 30, 2023 -291.63%
Mar 31, 2023 -217.47%
Dec 31, 2022 -289.66%
Sep 30, 2022 -168.73%
Jun 30, 2022 -164.95%
Mar 31, 2022 -135.00%
Dec 31, 2021 -98.59%
Sep 30, 2021 -71.59%
Jun 30, 2021 -49.67%
API Access

Taysha Gene Therapies Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TSHA&period=max&api_key=YOUR_API_KEY